Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
25 and 50 mg diclofenac K film coated immediate release tablets More
The unique ORS effervescent tablet has been developed according to the latest guidelines of the WHO. It has a substantial marketshare in several countries. We are looking for partners to further expand this success. More
Fentanyl patch for the management of severe pain in patients who require continuous opioid analgesia. More
25mg dosage strenght for the OTC market in film coated tablets More
Range of Glucosamine based pharmaceutical products (capsule,tablets,sachets,) authorized in some countries of Europe or ready to register. More
Superior Alternative to Pads and Tampons More
The First Line of Therapy in Severe Migraine Attacks More
Cliovelle - a low dose Estradiol / Progestin combination product for treatment of menopausal disorders. More
25mg dosage strenght for the OTC market More
The ‘green technology’ allows the extraction of cosmetically active compounds from plants using root exudation without harming the plants involved. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2010 - 27 pages - $99
Apr 2010 - 17 pages - $99
Nov 2010 - 23 pages - $99
Nov 2010 - 24 pages - $99
Sep 2010 - 24 pages - $99
Sep 2010 - 27 pages - $99
Aug 2010 - 22 pages - $99
Dec 2010 - 26 pages - $99
Nov 2010 - 26 pages - $99
Apr 2010 - 24 pages - $99
Your selection
Browse By
- Industry sector
- Generics
- Nutrition
- OTC/Non-Prescription
- Pediatric
- Personal Care
- Prescription
- Therapeutic target
- Accident and Trauma
- Allergy
- Blood and forming organs
- Cardiovascular
- Central Nervous System
- Dermatological
- Endocrinology
- Gastrointestinal
- Genetic disorders
- Genito-urinary
- Hospital and Surgery
- Immune related disorders
- Infectious diseases
- Metabolism
- Musculoskeletal
- Oncology
- Oral Health
- Other therapeutic
- Respiratory
- Sensory organ
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us